TY - JOUR
T1 - Involvement of lipid rafts in multiple signal transductions mediated by two isoforms of thromboxane A2 receptor
T2 - Dependency on receptor isoforms and downstream signaling types
AU - Goto, Shinji
AU - Saito, Masaki
AU - Obara, Yutaro
AU - Moriya, Takahiro
AU - Nakahata, Norimichi
N1 - Funding Information:
This work was supported in part by a Grand-in-Aid for Scientific Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan [Grant 22700325 (to T.M.)]
PY - 2012/10/15
Y1 - 2012/10/15
N2 - Lipid rafts, microdomains in the plasma membrane, are known to be involved in G protein-coupled receptor signal transduction; however, their involvement in thromboxane A2 receptor (TP) signaling remains to be clarified. We examined whether two isoforms of TP, TPα and TPβ, utilize lipid rafts for multiple G protein signal transduction. Sucrose density gradient centrifugation followed by western blotting of HEK cells expressing TPα or TPβ revealed the localization of both TPα and TPβ in lipid rafts. Furthermore, methyl-β-cyclodextrin, which destroys lipid raft structure by depleting cholesterol, influenced G protein signaling elicited by TPα and TPβ to varying degrees. Phosphatidylinositol hydrolysis and cAMP accumulation induced by TPα or TPβ stimulation was markedly inhibited by methyl-β-cyclodextrin. In contrast, treatment with methyl-β-cyclodextrin partially inhibited RhoA activation induced by TPα stimulation, but failed to affect TPβ stimulation. Furthermore, the inhibitory action of methyl-β-cyclodextrin on cAMP accumulation was specific to TPα and TPβ, because methyl-β-cyclodextrin enhanced forskolin and β-adrenergic stimulation-induced cAMP accumulation. These results indicate that TP isoforms depend on lipid rafts during Gq and Gs signaling, while G13 signaling mediated by TP isoforms does not. Moreover, TPα seems to be more lipid raft-dependent with respect to RhoA activation than TPβ. These results indicate that the two isoforms of the TP mediate multiple signal transductions with varying degrees of lipid raft dependency. Moreover, our results provide a deeper understanding of the function of lipid rafts in G protein signaling and the physiological meaning of TP isoforms.
AB - Lipid rafts, microdomains in the plasma membrane, are known to be involved in G protein-coupled receptor signal transduction; however, their involvement in thromboxane A2 receptor (TP) signaling remains to be clarified. We examined whether two isoforms of TP, TPα and TPβ, utilize lipid rafts for multiple G protein signal transduction. Sucrose density gradient centrifugation followed by western blotting of HEK cells expressing TPα or TPβ revealed the localization of both TPα and TPβ in lipid rafts. Furthermore, methyl-β-cyclodextrin, which destroys lipid raft structure by depleting cholesterol, influenced G protein signaling elicited by TPα and TPβ to varying degrees. Phosphatidylinositol hydrolysis and cAMP accumulation induced by TPα or TPβ stimulation was markedly inhibited by methyl-β-cyclodextrin. In contrast, treatment with methyl-β-cyclodextrin partially inhibited RhoA activation induced by TPα stimulation, but failed to affect TPβ stimulation. Furthermore, the inhibitory action of methyl-β-cyclodextrin on cAMP accumulation was specific to TPα and TPβ, because methyl-β-cyclodextrin enhanced forskolin and β-adrenergic stimulation-induced cAMP accumulation. These results indicate that TP isoforms depend on lipid rafts during Gq and Gs signaling, while G13 signaling mediated by TP isoforms does not. Moreover, TPα seems to be more lipid raft-dependent with respect to RhoA activation than TPβ. These results indicate that the two isoforms of the TP mediate multiple signal transductions with varying degrees of lipid raft dependency. Moreover, our results provide a deeper understanding of the function of lipid rafts in G protein signaling and the physiological meaning of TP isoforms.
KW - Lipid raft
KW - Phosphatidylinositol hydrolysis
KW - RhoA
KW - Thromboxane A receptor
KW - cAMP
UR - http://www.scopus.com/inward/record.url?scp=84866283403&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866283403&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2012.07.046
DO - 10.1016/j.ejphar.2012.07.046
M3 - Article
C2 - 22963705
AN - SCOPUS:84866283403
SN - 0014-2999
VL - 693
SP - 15
EP - 24
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-3
ER -